Sep 28, 2026 11:51AM
Sep 28, 2026 06:31AM
Sep 28, 2026 06:30AM
Aug 13, 2026 04:00PM
May 7, 2026 04:00PM
May 1, 2026 12:23AM
Mar 31, 2026 04:45PM Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Mar 26, 2026 06:01AM
Mar 26, 2026 06:00AM
Jan 7, 2026 12:44AM
Dec 15, 2025 04:39PM
Nov 13, 2025 04:05PM
Aug 13, 2025 04:00PM
May 14, 2025 04:15PM Kodiak Sciences Announces Recent Business Highlights and First Quarter 2025 Financial Results
Mar 27, 2025 04:01PM
Mar 10, 2025 04:39PM
Nov 14, 2024 04:01PM
Aug 14, 2024 04:01PM
May 15, 2024 04:01PM
Mar 28, 2024 06:30AM
Dec 11, 2023 06:26AM Goldman Sachs Reinstates Kodiak Sciences Inc. (KOD) at Sell, 'Cautious on the tarcocimab reboot'
Nov 14, 2023 04:01PM
Nov 6, 2023 05:00AM
Mar 28, 2023 04:08PM
Feb 9, 2023 07:30AM
Aug 9, 2022 04:33PM
Aug 8, 2022 06:30AM
Aug 8, 2022 06:30AM Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion
May 19, 2022 08:00AM
Feb 3, 2022 05:33AM
Feb 3, 2022 05:30AM
Dec 16, 2021 05:30AM
Sep 1, 2021 05:45AM
Dec 3, 2020 11:00AM
Nov 16, 2020 06:53AM Kodiak Sciences Inc. (KOD) Reports Complete Enrollment of DAZZLE Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration
Nov 16, 2020 06:53AM
Nov 11, 2020 11:27PM
Nov 9, 2020 05:30AM
Aug 10, 2020 05:30AM
Jul 16, 2020 04:38PM
Jul 10, 2020 04:02PM
Jul 10, 2020 04:00PM Kodiak Sciences Announces New Longer-Term Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and
May 11, 2020 05:30AM
Mar 16, 2020 05:30AM
Mar 3, 2020 04:49AM
Dec 3, 2019 09:16AM
Nov 12, 2019 05:30AM

334,274 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All